# Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

> **NCT00331825** · PHASE4 · COMPLETED · sponsor: **Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan** · enrollment: 70 (—)

## Conditions studied

- Schizophrenia
- Extrapyramidal Syndrome

## Interventions

- **DRUG:** Risperidone and Olanzapine

## Key facts

- **NCT ID:** NCT00331825
- **Lead sponsor:** Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** —
- **Final completion:** 2003-07
- **Target enrollment:** 70 (—)
- **Last updated:** 2006-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331825, "Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00331825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*